Browsing Tag
AdaptHealth Corp.
2 posts
Cardinal Health lifts EPS outlook to $13 as specialty drug profits surge 17%
Cardinal Health has raised its fiscal 2027 earnings outlook after strong growth in pharmaceutical distribution and specialty products. However, declining medical-products profitability and the contribution of tax and share-count changes warrant closer examination.
Cardinal Health (NYSE: CAH) to buy AdaptHealth’s Diabetes Health arm and Strive Medical for $360m
Cardinal Health to pay $235 million for AdaptHealth's Diabetes Health arm plus Strive Medical for $360M combined ahead of the 11 August fiscal 2026 results release.